Expression of apoptosis-related proteins in experimental coxsakievirus myocarditis

Cardiovascular Research

Volumn 38, Issue 1, 1998, Pages 158-168

  Colston, James T ^a   Chandrasekar, Bysani ^a   Freeman, Gregory L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; C3H.HeJ; CD1; Coxsackievirus; Immunohistochemistry; Mice; Myocarditis

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 1BETA CONVERTING ENZYME; NITRIC OXIDE SYNTHASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTO ONCOGENE; VIRUS MYOCARDITIS;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; FAS LIGAND PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED STRAINS; MYOCARDITIS; MYOCARDIUM; NECROSIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SPLEEN; THYMUS GLAND;

EID: 0032052017     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00323-4     Document Type: Article

References (49)

1. [1] Reyes MP, Lerner AM. Myocarditis: clinical and experimental correlates. In: Bendinelli M, Friedman H, editors. Coxsackieviruses: a general update, New York: Plenum Press, 1988:253-269.
2. [2] Freeman GL, Colston JT, Zabalgoitia M, Chandrasekar B. Contractile depression and expression of proinflammatory cytokines and inducible nitric oxide synthase in viral myocarditis. Am J Physiol 1998;274:H249-H258.
3. [3] Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389.
4. [4] Hosenpud JD. The effects of interleukin-1 on myocardial function and metabolism. Clin Immunol Immunopathol 1993;68:175-180.
5. [5] Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorn VL, Culhane AC, Williams GT. Apoptosis: molecular regulation of cell death. Eur J Biochem 1996;236:1-26.
6. [6] James TN. Normal and abnormal consequences of apoptosis in the human heart. Circulation 1994;90(1):556-573.
7. [7] Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992;10:267-293.
8. [8] Tewari M, Dixit VM. Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 1995;270:3255-3260.
9. [9] Guide to the Care and Use of Animals. DHEW Publication No. (NIH) 85-23, Revised 1985, Office of Science and Health Reports, DRR/NIH, Bethesda, MD, 20205.
10. [10] Henke A, Mohr C, Sprenger H, Graebner C, Stelzner A, Nain M, Gemsa D. Coxsackievirus B3-induced production of tumor necrosis factor-α, IL-1β, and IL-6 in human monocytes. J Immunol 1992;148:2270-2277.
11. [11] Lane JR, Neumann DA, Lanfond-Walker A, Herskowitz A, Rose NR. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol 1993;151(3):1682-1690.
12. [12] Afford SC, Pongracz J, Stockley RA, Crocker J, Burnett D. The induction by human interleukin-6 of apoptosis in promonocytic cell line U937 and human neutrophils. J Biol Chem 1992;267(30):21612-21616.
13. [13] Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993;150:5080-5085.
14. [14] Geng Y-J, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1β. Arterioscler Thromb Vasc Biol 1996;16:19-27.
15. [15] Messmer UK, Lapetina EG, Brune B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C-and protein kinase A-activating compounds. Mol Pharmacol 1995;47:757-765.
16. [16] Collins M. Potential roles of apoptosis in viral pathogenesis. Am J Crit Care Med 1995;152:S20-S24.
17. [17] Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
18. [18] Karsan A, Yee E, Kaushansky K, Harlan JM. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 1996;87(8):3089-3096.
19. [19] Keeling PJ, Jeffrey S, Caforio AL, Taylor R, Bottazzo GF, Davies MJ, McKenna WJ. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br Heart J 1992;68:554-559.
20. [20] Rabausch-Starz I, Schwaiger A, Grunewald K, Muller-Hermelink H-K, Neu N. Persistence of virus and viral genome in myocardium after coxsackievirus B3-induced myocarditis. Clin Exp Immunol 1994;96:69-74.
21. [21] Kajstura J, Mansukhani M, Cheng W, Reiss K, Drajewski S, Reed JC, Quaini F, Sonnenblick EH, Anversa P. Programmed cell death and expression of protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exper Cell Res 1995;219:110-121.
22. [22] Oltvai ZN, Milliman CL, Korsmeyer J. Bcl-2 heterodimerizes in vivo with a conserved homologue Bax, that accelerates programmed cell death. Cell 1993;4:609-619.
23. [23] Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995;374:736-739.
24. [24] Krajewski S, Krajewski M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994;145(6):1323-1336.
25. [25] Ohta K, Iwai K, Kasahara Y, Taniguchi N, Krajewski S, Reed JC, Miyawaki T. Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues. Int Immunol 1995;7(11):1817-1825.
26. [26] Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer J. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 1995;80:285-291.
27. [27] Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-1455.
28. 2+)-independent T cell-mediated cytotoxicity. J Exp Med 1993;177:195-200.
29. [29] Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279.
30. [30] Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis family. Cell 1993;75:1169-1178.
31. [31] Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of a human fas ligand in activated lymphocytes. EMBO J 1995;4(6):1129-1135.
32. [32] Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;54:3806-3813.
33. [33] Black RA, et al. Generation of biologically active interleukin-1β by proteolytic cleavage of the inactive precursor. J Biol Chem 1988;263:9437-9442.
34. [34] Alnemri ES, Fernandes-Alnemri T, Litwack G. Cloning and expression of four novel isoforms of human interleukin-1β converting enzyme with different apoptotic activities. J Biol Chem 1996;270(9):4312-4317.
35. [35] Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma. Am J Pathol 1995;147(2):251-266.
36. [36] Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 1991;88:8485-8489.
37. [37] Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS-S, Flavell RA. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 1995;267:2000-2003.
38. [38] Singer II, Scott S, Chin J, Bayne EK, Limjuco G, Weidner J, Miller DK, Chapman K, Kostura MJ. The interleukin-1β-converting enzyme (ICE) is localized to the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J Exp Med 1995;182:1447-1459.
39. [39] Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994;54:3131-3135.
40. [40] Miyashita T, Reed JC. Tumor-suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-299.
41. [41] Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
42. [42] Geng Y-J, Petersson AS, Wennmalm A, Hansson GK. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp Cell Res 1994;214:418-428.
43. [43] Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-1628.
44. [44] Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426-433.
45. [45] Kawano H, Okada R, Kawano Y, Sueyoshi N, Shirai T. Apoptosis in acute and chronic myocarditis. Jpn Heart J 1994;35:745-750.
46. [46] Savill J, Fadok V, Henson P, Haslett C. Phagocytic recognition of cells undergoing apoptosis. Immunol Today 1993;14:131-136.
47. [47] Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by the Bcl-2 oncogene. Nature 1993;361:739-742.
48. [48] Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR. Variations in the susceptibility of coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol 1986;136:1853-1856.
49. [49] Birnbaum MJ, Clem RJ, Miller LK. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His motifs. J Virol 1994;68:2521-2528.